I

Invesco Perpetual

412 employees

Invesco Perpetual specializes in active investing, passive (ETFs and ETCs), ESG, and factor investing.

Investor insights

Sectors invested in

Biotechnology2
Genetics1
Virus Services1
Protein Production Services1
Cell Line Development Services.1
PRODUCTS: Largest collection of standardised plasmids on the market and SERVICES: DNA Services1
celltherapy1
clinical trial1
CAR-NKT1
Health Care1
CAR1
T cells1
Cancer1
NKT Cells1
Medical1
lifesciences1
Oncology1
TCR1
Immunotherapy1

Funding rounds participated in

$21M sweet spot round size

Most of their 4 investments are in rounds between $9.1M and $33M

Basic info

Industry

investment management

Sectors

Date founded

1982

Investments made

U

Undisclosed raised $9.1M on December 9, 2018

Investors: Oxford Sciences Innovation, Foresite Capital, Woodford Investment Management, Vertex Pharmaceuticals, IP Group plc, F-Prime Capital Partners and Invesco Perpetual

U

Undisclosed raised $33M on August 30, 2018

Investors: Oxford Sciences Innovation, Woodford Investment Management, IP Group plc, Lansdowne Partners, Vertex Pharmaceuticals and Invesco Perpetual

O

OXGENE raised $9.7M on August 21, 2017

Investors: Invesco Perpetual

K

Kuur Therapeutics raised $73M on March 15, 2017

Investors: Woodford Investment Management, TOUCHSTONE INNOVATIONS PLC and Invesco Perpetual

FAQ